Retrospective Biomarker Analysis Performed To Measure Tumor-infiltrating CD39+ CD8+ T Cells in metastatic Renal Cell Carcinoma

Download Cerba Research’s case study to find out about retrospective biomarker analysis is performed to measure tumour-infiltrating.

Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)

Discover how we managed cell isolation and counts among other routine and speciality tests for a large Relapse Refractory Multiple Myeloma  study over 11,000 samples managed.

Tests including FCM, PBMC isolation and count, FISH

Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)

Discover how we manage routine and specialty test for a Phase 1 study

Phase 3 CAR-T vs SOC in Relapse Refractory Multiple Myeloma (RRMM)

Discover how effective we are in immunophenotyping for a Car-T therapy take a look at this case study

Case Study: How Cerba Research Helped Advance a Phase IIB Study in the Middle of a Pandemic and Brexit

Cerba conducted a two-country clinical trial that involves a nasopharyngeal swab and two assays. Although it sounds relatively straightforward, conducting a study during a global pandemic and Brexit is bound to be a struggle.

A combination of creative logistics, careful planning and a strong customer relationships allowed Cerba Research to keep sample processing for a novel COVID-19 treatment on track in the middle of extraordinary upheaval.

Download our case study to find out more.

How To Improve the Patients Experience in IO Clinical Trials – with the Gustave Roussy Institute

Cerba Research conducted a case study on patient experience in Immuno Oncology trials at Gustave Roussy’s Cancer Research Center. it is clear that the therapeutic future lies in biomarkers through the development of immunotherapies and companion diagnostics.

Florian Scotté and Adrien Ko, present in the webinar the Patient Connect Solution and the effects expected on the patient pathway in Immuno Oncology trials.

Watch our webinar now to find out more.


Tech Transfer IFE Reflex Assay China

A Biotech Company in China required our scientific expertise for the Tech Transfer of IFE Reflex Assay on a clinical trial in the Oncology field (Relapsed or Refractory Multiple Myeloma). Cerba Research was not the Biotech’s central or specialty laboratory on the study but brought in for our expertise on the tech transfer.

Download the case study to read more.

Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)

Lab support for a global pediatric trial for the rare genetic neurodegenerative disorder, Mucopolysaccharidosis type III. Cerba Research provided safety testing, sample management, and specialized testing in our histology lab. Read the case study to discover more details.

Pediatric Phase I/II/III Study in X-Linked Myotubular Myopathy (XLMTM)

Lab support for a global pediatric trial for the rare neuromuscular disease, Myotubular Myopathy. Cerba Research provides safety testing, PBMC isolation, biomarkers, and sample management for the clinical trial. Read more on the challenges and solutions in the case study.

Lab Support for the Largest Global Phase III NASH Study to Date